WO1997030092A2 - Hydrogels - Google Patents
Hydrogels Download PDFInfo
- Publication number
 - WO1997030092A2 WO1997030092A2 PCT/GB1997/000420 GB9700420W WO9730092A2 WO 1997030092 A2 WO1997030092 A2 WO 1997030092A2 GB 9700420 W GB9700420 W GB 9700420W WO 9730092 A2 WO9730092 A2 WO 9730092A2
 - Authority
 - WO
 - WIPO (PCT)
 - Prior art keywords
 - hydrogel
 - cross
 - linked
 - polysaccharide
 - chitosan
 - Prior art date
 
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 66
 - 150000004676 glycans Chemical class 0.000 claims abstract description 42
 - 229920001661 Chitosan Polymers 0.000 claims abstract description 38
 - 229920001282 polysaccharide Polymers 0.000 claims abstract description 33
 - 239000005017 polysaccharide Substances 0.000 claims abstract description 33
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
 - OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims abstract description 8
 - DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
 - 239000000499 gel Substances 0.000 claims description 16
 - 229920002907 Guar gum Polymers 0.000 claims description 13
 - 239000000665 guar gum Substances 0.000 claims description 13
 - 235000010417 guar gum Nutrition 0.000 claims description 13
 - 229960002154 guar gum Drugs 0.000 claims description 13
 - 229920002230 Pectic acid Polymers 0.000 claims description 12
 - 229920000642 polymer Polymers 0.000 claims description 12
 - BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 11
 - OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 11
 - LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 10
 - 238000004132 cross linking Methods 0.000 claims description 9
 - 239000010318 polygalacturonic acid Substances 0.000 claims description 9
 - 238000006243 chemical reaction Methods 0.000 claims description 8
 - ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 7
 - -1 borate ions Chemical class 0.000 claims description 6
 - 150000002500 ions Chemical class 0.000 claims description 6
 - OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
 - 229910052791 calcium Inorganic materials 0.000 claims description 5
 - 239000011575 calcium Substances 0.000 claims description 5
 - 125000002843 carboxylic acid group Chemical group 0.000 claims description 5
 - 150000001768 cations Chemical class 0.000 claims description 5
 - 150000005846 sugar alcohols Polymers 0.000 claims description 5
 - 239000002253 acid Substances 0.000 claims description 4
 - WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
 - 239000002202 Polyethylene glycol Substances 0.000 claims description 3
 - AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims description 3
 - 239000001814 pectin Substances 0.000 claims description 3
 - 229920001277 pectin Polymers 0.000 claims description 3
 - 235000010987 pectin Nutrition 0.000 claims description 3
 - 229920001223 polyethylene glycol Polymers 0.000 claims description 3
 - 229920000161 Locust bean gum Polymers 0.000 claims description 2
 - 229910052783 alkali metal Inorganic materials 0.000 claims description 2
 - 239000000711 locust bean gum Substances 0.000 claims description 2
 - 235000010420 locust bean gum Nutrition 0.000 claims description 2
 - 229920001515 polyalkylene glycol Polymers 0.000 claims description 2
 - 229910001428 transition metal ion Inorganic materials 0.000 claims description 2
 - 239000000203 mixture Substances 0.000 description 14
 - QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
 - 206010052428 Wound Diseases 0.000 description 10
 - 208000027418 Wounds and injury Diseases 0.000 description 10
 - 239000003431 cross linking reagent Substances 0.000 description 9
 - 239000012153 distilled water Substances 0.000 description 9
 - 239000000243 solution Substances 0.000 description 9
 - HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
 - UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
 - 239000001110 calcium chloride Substances 0.000 description 5
 - 229910001628 calcium chloride Inorganic materials 0.000 description 5
 - 239000012530 fluid Substances 0.000 description 5
 - BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
 - 229910001424 calcium ion Inorganic materials 0.000 description 4
 - 229920001577 copolymer Polymers 0.000 description 4
 - 238000000034 method Methods 0.000 description 4
 - 239000000047 product Substances 0.000 description 4
 - 125000003277 amino group Chemical group 0.000 description 3
 - 230000006866 deterioration Effects 0.000 description 3
 - KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 3
 - WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
 - GUQJTTJZPGRWIK-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;prop-2-enoic acid Chemical group OC(=O)C=C.C=CN1CCCC1=O GUQJTTJZPGRWIK-UHFFFAOYSA-N 0.000 description 2
 - 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
 - LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
 - 229910021538 borax Inorganic materials 0.000 description 2
 - 150000001718 carbodiimides Chemical class 0.000 description 2
 - 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
 - 210000000416 exudates and transudate Anatomy 0.000 description 2
 - 239000004328 sodium tetraborate Substances 0.000 description 2
 - 235000010339 sodium tetraborate Nutrition 0.000 description 2
 - FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
 - WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
 - 229920000926 Galactomannan Polymers 0.000 description 1
 - SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
 - OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
 - DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
 - 208000005230 Leg Ulcer Diseases 0.000 description 1
 - 239000004677 Nylon Substances 0.000 description 1
 - 208000004210 Pressure Ulcer Diseases 0.000 description 1
 - 229920000297 Rayon Polymers 0.000 description 1
 - RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
 - 239000003929 acidic solution Substances 0.000 description 1
 - 239000012190 activator Substances 0.000 description 1
 - 125000003172 aldehyde group Chemical group 0.000 description 1
 - 150000001408 amides Chemical class 0.000 description 1
 - 239000004599 antimicrobial Substances 0.000 description 1
 - 230000015572 biosynthetic process Effects 0.000 description 1
 - 229940063013 borate ion Drugs 0.000 description 1
 - 150000001720 carbohydrates Chemical class 0.000 description 1
 - 235000014633 carbohydrates Nutrition 0.000 description 1
 - 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
 - 239000000969 carrier Substances 0.000 description 1
 - 230000015556 catabolic process Effects 0.000 description 1
 - 239000007795 chemical reaction product Substances 0.000 description 1
 - 239000003638 chemical reducing agent Substances 0.000 description 1
 - 230000015271 coagulation Effects 0.000 description 1
 - 238000005345 coagulation Methods 0.000 description 1
 - 239000006071 cream Substances 0.000 description 1
 - 229920006037 cross link polymer Polymers 0.000 description 1
 - 238000001804 debridement Methods 0.000 description 1
 - 238000006731 degradation reaction Methods 0.000 description 1
 - CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
 - 238000002474 experimental method Methods 0.000 description 1
 - 239000003102 growth factor Substances 0.000 description 1
 - 230000035876 healing Effects 0.000 description 1
 - 230000036571 hydration Effects 0.000 description 1
 - 238000006703 hydration reaction Methods 0.000 description 1
 - WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
 - 238000007654 immersion Methods 0.000 description 1
 - 238000004519 manufacturing process Methods 0.000 description 1
 - 239000012528 membrane Substances 0.000 description 1
 - 229920001778 nylon Polymers 0.000 description 1
 - 239000004014 plasticizer Substances 0.000 description 1
 - 150000004804 polysaccharides Polymers 0.000 description 1
 - 230000001737 promoting effect Effects 0.000 description 1
 - QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
 - 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
 - 229910052708 sodium Inorganic materials 0.000 description 1
 - 239000011734 sodium Substances 0.000 description 1
 - 239000012279 sodium borohydride Substances 0.000 description 1
 - 229910000033 sodium borohydride Inorganic materials 0.000 description 1
 - 239000003381 stabilizer Substances 0.000 description 1
 - 230000008961 swelling Effects 0.000 description 1
 - 229910052719 titanium Inorganic materials 0.000 description 1
 - 239000010936 titanium Substances 0.000 description 1
 - 229920002554 vinyl polymer Polymers 0.000 description 1
 
Classifications
- 
        
- C—CHEMISTRY; METALLURGY
 - C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
 - C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
 - C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
 - C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
 - C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
 - A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
 - A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
 - A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
 - A61L15/225—Mixtures of macromolecular compounds
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
 - A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
 - A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
 - A61L15/42—Use of materials characterised by their function or physical properties
 - A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
 - A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
 - A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
 - A61L26/0052—Mixtures of macromolecular compounds
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
 - A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
 - A61L26/0061—Use of materials characterised by their function or physical properties
 - A61L26/008—Hydrogels or hydrocolloids
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
 - C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
 - C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
 - C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
 - C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
 - C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
 - C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
 
 
Definitions
- the present invention relates to hydrogels which are intended particularly, but
 - Hydrogels are water-swollen, three dimensionally cross-linked hydrophilic
 - polymers which are typically formed by cross-linking the polymer under aqueous conditions using a low amount of cross-linking agent so that a water-swollen, cross ⁇
 - the amount of cross-linking agent should not be too
 - the cross-links are usually either
 - (5) can (if required) also form carriers for antimicrobial agent or growth factors or
 - hydrogel comprising a cross-linked form of at least one water soluble polysaccharide selected from
 - Hydrogels in accordance with the invention are derived from the biocompatible and biodegradable polysaccharides identified under (i)-(ii) and may be
 - hydrogels comprised of the
 - cross-linked form of (i) and/or (ii) may optionally further comprise a cross-linked
 - Hydrogels in accordance with the invention are capable, when used as wound
 - hydrogels of the invention are quantities of fluid than current commercial hydrogels.
 - hydrogels (i) in accordance with the invention are those derived
 - galactomannan is a polysaccharide comprised of galactomannan residues
 - polymer of D-galactose and D-mannose examples of polymers comprising
 - galactomannan residues which may be used in accordance with the invention are those
 - guar gum derived from seed gums. e.g. guar gum and locust bean gum.
 - Hydrogels may be produced from the polysaccharide (i) by effecting cross ⁇
 - an alkali metal borate e.g. sodium
 - transition metal ions such as titanium
 - Hydrogels may be produced from the polysaccharide (i) by admixed with
 - the reaction is preferably effected at a pH
 - polysaccharide (i) is 1% to 6% w/v of the admixture, more preferably 1% to 5% on
 - Gels produced by this method may be either
 - the amount of the cross-linking agent may be up to about 0.2% w/v.
 - Hydrogels produced from polysaccharides (ii) may be obtained in a number of
 - chitosan derivatives such as carboxymethyl chitosan.
 - chitosan may be cross-linked using a dialdehyde which reacts with
 - dialdehyde is preferably of the formula
 - This cross-linking reaction is preferably effected in an acidic solution (e.g. at a pH of about 4) of the chitosan.
 - the amount of chitosan will be used in the range 1% to 6% w/v (e.g. about
 - dialdehyde 3% w/v
 - dialdehyde 3% w/v
 - This method is particularly suitable for the production of hydrogels in sheet form.
 - chitosan may be cross-linked using a dicarboxylic acid, preferably
 - polyalkylene glycol dicarboxylic acid is a polyalkylene glycol dicarboxylic acid (preferred molecular weight range 200
 - polysaccharide chains are cross-linked by diamide linkages.
 - chitosan is 1% to 6% w/v and the amount of dicarboxylic acid is 1 to 2% w/v.
 - compositions are suitable as amorphous hydrogels.
 - the chitosan may be reacted with a polymer having carboxylic acid
 - a suitable co-polymer is N-vinyl pyrrolidone acrylic acid
 - NDP-AA N-AA
 - hydrogel (preferably calcium) to form a hydrogel.
 - a hydrogel comprises 2%-
 - polysaccharides (i) or (ii) may further comprise a cross-linked form of a
 - polysaccharide (iii) i.e. pectin, pectic acid or pectate
 - pectin i.e. pectin, pectic acid or pectate
 - polysaccharide (iii) in the hydrogel is preferably in the range 2 to 4% w/v and
 - multivalent cation is present in an amount up to 0.2% w/v, e.g. 0.02% w/v.
 - the former may be
 - polysaccharide (i) and/or (ii) improves the adhesion of the latter in wounds as well as
 - polyhydric alcohol e.g. in an amount up to 20% w/v
 - the preferred polyhydric alcohol is propylene glycol
 - Fig 1 illustrates a part of the structure of guar gum.
 - Fig 2 illustrates the cross-linking of guar gum with a borate.
 - Fig 3 illustrates a hydrogel comprised of a mixture of (a) guar gum (chain 1 )
 - Fig 4 illustrates the structure of chitosan.
 - Fig. 5 illustrates the cross-linking of chitosan with glutaraldeyde.
 - Fig 6 illustrates chitosan modified by reaction with a N-vinylpyrrolidone
 - Figs 1 and 2 are generally self-explanatory, the former showing a portion of
 - FIG 3 there is schematically illustrated a product which
 - guar gum chain is represented by reference numeral 1 and is shown to be cross-linked
 - reference numeral 2 is shown to be cross-linked by calcium ions.
 - Fig 4 illustrates a portion of the structure of chitosan whereas Fig 5 illustrates
 - N-vinylpyrrolidone acrylic acid co-polymer More particularly, a portion of the
 - carboxylic acid groups on the co-polymer react with amino groups of the chitosan (to)
 - the modified chitosan may then be cross-linked using
 - the mixture was then homogenised with the aid of a high shear mixer.
 - hydrogel This hydrogel is cream coloured, thick, and paste-like. It was autoclaved at 121 °C for 15 minutes without apparent deterioration of the gel.
 - EDC Ethyl-3-(-3-Diethyl amino propyl) Carbodiimide
 - the gel was reacted further with a reducing agent such as sodium borohydride
 - Pectic acid (2g) was suspended in 1 1 ml of water and it was dissolved when the pH of the solution was raised to 3 after the addition of diluted
 - ion source e.g. 0.02g calcium chloride
 - a divalent ion source e.g. 0.024 g of calcium chloride
 - distilled water was homogenised with aid of high sheer mixture before the cast as a
 
Landscapes
- Health & Medical Sciences (AREA)
 - Chemical & Material Sciences (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Materials Engineering (AREA)
 - General Health & Medical Sciences (AREA)
 - Engineering & Computer Science (AREA)
 - Public Health (AREA)
 - Epidemiology (AREA)
 - Veterinary Medicine (AREA)
 - Animal Behavior & Ethology (AREA)
 - Molecular Biology (AREA)
 - Organic Chemistry (AREA)
 - Dispersion Chemistry (AREA)
 - Polymers & Plastics (AREA)
 - Medicinal Chemistry (AREA)
 - Biochemistry (AREA)
 - Chemical Kinetics & Catalysis (AREA)
 - Hematology (AREA)
 - Emergency Medicine (AREA)
 - Medicinal Preparation (AREA)
 - Cosmetics (AREA)
 - Compositions Of Macromolecular Compounds (AREA)
 - Processes Of Treating Macromolecular Substances (AREA)
 
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| AU18025/97A AU1802597A (en) | 1996-02-15 | 1997-02-14 | Hydrogels | 
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB9603146.3 | 1996-02-15 | ||
| GBGB9603146.3A GB9603146D0 (en) | 1996-02-15 | 1996-02-15 | Hydrogels | 
Publications (2)
| Publication Number | Publication Date | 
|---|---|
| WO1997030092A2 true WO1997030092A2 (en) | 1997-08-21 | 
| WO1997030092A3 WO1997030092A3 (en) | 1997-11-20 | 
Family
ID=10788772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| PCT/GB1997/000420 WO1997030092A2 (en) | 1996-02-15 | 1997-02-14 | Hydrogels | 
Country Status (3)
| Country | Link | 
|---|---|
| AU (1) | AU1802597A (en) | 
| GB (1) | GB9603146D0 (en) | 
| WO (1) | WO1997030092A2 (en) | 
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US6316506B2 (en) | 1997-07-29 | 2001-11-13 | Alcon Laboratories, Inc. | Conditioning solutions for contact lens care | 
| US6403609B1 (en) | 1997-07-29 | 2002-06-11 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate | 
| US6413494B1 (en) * | 1998-07-23 | 2002-07-02 | Samyang Corporation | Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides | 
| US6495608B1 (en) | 1997-07-29 | 2002-12-17 | Alcon Manufacturing, Ltd. | Methods of performing surgery with galactomannan polymers and borate | 
| US6998509B1 (en) | 1999-10-07 | 2006-02-14 | Coloplast A/S | Wound care device | 
| US8101196B2 (en) | 2001-06-26 | 2012-01-24 | Biointeractions, Ltd. | Polysaccharide biomaterials and methods of use thereof | 
| WO2015200541A1 (en) | 2014-06-24 | 2015-12-30 | Bio-Rad Laboratories, Inc. | Digital pcr barcoding | 
| WO2017165620A1 (en) | 2016-03-24 | 2017-09-28 | Bio-Rad Laboratories, Inc. | Use of gel beads to control droplet dispersion | 
| WO2018118971A1 (en) | 2016-12-19 | 2018-06-28 | Bio-Rad Laboratories, Inc. | Droplet tagging contiguity preserved tagmented dna | 
| WO2018208632A1 (en) * | 2017-05-12 | 2018-11-15 | Corning Incorporated | A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery | 
| WO2018236918A1 (en) | 2017-06-20 | 2018-12-27 | Bio-Rad Laboratories, Inc. | MDA USING A BALL OLIGONUCLEOTIDE | 
| WO2019089959A1 (en) | 2017-11-02 | 2019-05-09 | Bio-Rad Laboratories, Inc. | Transposase-based genomic analysis | 
| CN109867729A (en) * | 2019-03-05 | 2019-06-11 | 北京林业大学 | Photoresponse type galactomannans hydrogel and preparation method thereof | 
| WO2019152395A1 (en) | 2018-01-31 | 2019-08-08 | Bio-Rad Laboratories, Inc. | Methods and compositions for deconvoluting partition barcodes | 
| WO2020041293A1 (en) | 2018-08-20 | 2020-02-27 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions | 
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4333461A (en) * | 1979-12-17 | 1982-06-08 | Colgate-Palmolive Company | Borated polysaccharide absorbents and absorbent products | 
| DE4026153A1 (en) * | 1990-08-17 | 1992-02-20 | Sebapharma Gmbh & Co | Wound bandage | 
| US5420197A (en) * | 1994-01-13 | 1995-05-30 | Hydromer, Inc. | Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives | 
| US5578661A (en) * | 1994-03-31 | 1996-11-26 | Nepera, Inc. | Gel forming system for use as wound dressings | 
- 
        1996
        
- 1996-02-15 GB GBGB9603146.3A patent/GB9603146D0/en active Pending
 
 - 
        1997
        
- 1997-02-14 WO PCT/GB1997/000420 patent/WO1997030092A2/en active Application Filing
 - 1997-02-14 AU AU18025/97A patent/AU1802597A/en not_active Abandoned
 
 
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US6316506B2 (en) | 1997-07-29 | 2001-11-13 | Alcon Laboratories, Inc. | Conditioning solutions for contact lens care | 
| US6403609B1 (en) | 1997-07-29 | 2002-06-11 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate | 
| US6486215B2 (en) | 1997-07-29 | 2002-11-26 | Alcon Manufacturing, Ltd. | Solutions for treating contact lenses | 
| US6495608B1 (en) | 1997-07-29 | 2002-12-17 | Alcon Manufacturing, Ltd. | Methods of performing surgery with galactomannan polymers and borate | 
| US6583124B2 (en) | 1997-07-29 | 2003-06-24 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate | 
| US6838449B2 (en) | 1997-07-29 | 2005-01-04 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate | 
| US7169767B2 (en) | 1997-07-29 | 2007-01-30 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate | 
| US6413494B1 (en) * | 1998-07-23 | 2002-07-02 | Samyang Corporation | Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides | 
| US6998509B1 (en) | 1999-10-07 | 2006-02-14 | Coloplast A/S | Wound care device | 
| US7141714B2 (en) | 1999-10-07 | 2006-11-28 | Coloplast A/S | Wound care device | 
| US8101196B2 (en) | 2001-06-26 | 2012-01-24 | Biointeractions, Ltd. | Polysaccharide biomaterials and methods of use thereof | 
| US9127091B2 (en) | 2001-06-26 | 2015-09-08 | Biointeractions, Ltd. | Heparin coatings | 
| WO2015200541A1 (en) | 2014-06-24 | 2015-12-30 | Bio-Rad Laboratories, Inc. | Digital pcr barcoding | 
| US11155809B2 (en) | 2014-06-24 | 2021-10-26 | Bio-Rad Laboratories, Inc. | Digital PCR barcoding | 
| WO2017165620A1 (en) | 2016-03-24 | 2017-09-28 | Bio-Rad Laboratories, Inc. | Use of gel beads to control droplet dispersion | 
| WO2018118971A1 (en) | 2016-12-19 | 2018-06-28 | Bio-Rad Laboratories, Inc. | Droplet tagging contiguity preserved tagmented dna | 
| WO2018208632A1 (en) * | 2017-05-12 | 2018-11-15 | Corning Incorporated | A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery | 
| US12329820B2 (en) | 2017-05-12 | 2025-06-17 | Corning Incorporated | Cross-linked shear thinning fluid with tunable rheology for 3D bioprinting and drug delivery | 
| WO2018236918A1 (en) | 2017-06-20 | 2018-12-27 | Bio-Rad Laboratories, Inc. | MDA USING A BALL OLIGONUCLEOTIDE | 
| EP4180534A1 (en) | 2017-11-02 | 2023-05-17 | Bio-Rad Laboratories, Inc. | Transposase-based genomic analysis | 
| WO2019089959A1 (en) | 2017-11-02 | 2019-05-09 | Bio-Rad Laboratories, Inc. | Transposase-based genomic analysis | 
| WO2019152395A1 (en) | 2018-01-31 | 2019-08-08 | Bio-Rad Laboratories, Inc. | Methods and compositions for deconvoluting partition barcodes | 
| EP4324962A2 (en) | 2018-01-31 | 2024-02-21 | Bio-Rad Laboratories, Inc. | Methods and compositions for deconvoluting partition barcodes | 
| WO2020041293A1 (en) | 2018-08-20 | 2020-02-27 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions | 
| EP4249651A2 (en) | 2018-08-20 | 2023-09-27 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions | 
| CN109867729B (en) * | 2019-03-05 | 2020-12-01 | 北京林业大学 | Light-responsive galactomannan hydrogel and preparation method thereof | 
| CN109867729A (en) * | 2019-03-05 | 2019-06-11 | 北京林业大学 | Photoresponse type galactomannans hydrogel and preparation method thereof | 
Also Published As
| Publication number | Publication date | 
|---|---|
| AU1802597A (en) | 1997-09-02 | 
| WO1997030092A3 (en) | 1997-11-20 | 
| GB9603146D0 (en) | 1996-04-17 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| WO1997030092A2 (en) | Hydrogels | |
| US5502042A (en) | Methods and compositions for treating wounds | |
| US4994277A (en) | Use of xanthan gum for preventing adhesions | |
| US5116824A (en) | Biomaterial comprising a composite material of a chitosan derivative and collagen derivative | |
| ES2221070T3 (en) | ADHESIVE COMPOSITION WITH A MACROMOLECULAR BASE OF A POLYDEHYDE AND PROCEDURE FOR COLLAGEN RETICULATION. | |
| AU725296B2 (en) | Oxidized oligosaccharides | |
| ES2253827T3 (en) | USE OF HIALURONIC ACID DERIVATIVES IN THE PREPARATION OF BIOMATERIALS. | |
| EP1003526B1 (en) | Covalently linked n,o-carboxymethylchitosan and uses thereof | |
| US20090035356A1 (en) | Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings | |
| WO2002040055A2 (en) | Solutions and films of glycated chitosan | |
| US20090227537A1 (en) | Sulfated polysaccharides and uses thereof in medical treatment | |
| GB2314842A (en) | Protein/oxidised regenerated cellulose complexes | |
| JP2009529926A5 (en) | ||
| CA2153947A1 (en) | Sterile gel compositions for wound treatment | |
| CA2264647A1 (en) | Fragmented polymeric hydrogels for adhesion prevention and their preparation | |
| GB2275686A (en) | Swellable wound dressing materials | |
| CA2028709A1 (en) | Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions | |
| CN114099787B (en) | Absorbable biological membrane, preparation method and application thereof | |
| CN1539515A (en) | Biomaterial for preventing accretion after surgery and preparation method | |
| CA2470639A1 (en) | Preparation for wound healing and prevention of bandage adhesion to the wound | |
| US20080254015A1 (en) | Gel Composition of Citrus Complex Carbohydrates Cross-Linked with Cellulose Derivate | |
| CN115282328A (en) | An antibacterial hydrogel dressing | |
| EP1244709A4 (en) | REVERSIBLE NETWORKED HYDROGELS | |
| JPH0249745B2 (en) | ||
| CN109316625A (en) | A kind of sodium alga acid composition and its application | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| AK | Designated states | 
             Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM  | 
        |
| AL | Designated countries for regional patents | 
             Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF  | 
        |
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| NENP | Non-entry into the national phase | 
             Ref country code: JP Ref document number: 97529110 Format of ref document f/p: F  | 
        |
| REG | Reference to national code | 
             Ref country code: DE Ref legal event code: 8642  | 
        |
| 122 | Ep: pct application non-entry in european phase |